CG Oncology, Inc. Common stock
CGON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44 | -$41 | -$34 | -$32 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $7 | $5 | $5 |
| Change in WC | -$3 | $9 | $0 | $5 |
| Other Non-Cash | $0 | -$2 | -$0 | $1 |
| Operating Cash Flow | -$39 | -$28 | -$29 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | -$22 | $0 | $0 | $0 |
| Inv. Purchases | -$240 | -$168 | -$362 | -$217 |
| Inv. Sales/Matur. | $251 | $170 | $200 | $228 |
| Other Inv. Act. | $26 | -$1 | -$25 | $0 |
| Investing Cash Flow | $15 | $1 | -$187 | $11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $49 | -$0 | $0 | $223 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | $0 | $0 | -$0 |
| Financing Cash Flow | $54 | -$0 | $0 | $223 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $31 | -$27 | -$216 | $214 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15 | $41 | $257 | $43 |
| End Cash | $45 | $15 | $41 | $257 |
| Free Cash Flow | -$39 | -$28 | -$29 | -$21 |